Executive Committee
| The PSG is governed by a Constitution and Bylaws and an elected Executive Committee that is primarily responsible for the direction and oversight of its research projects and activities. |
|
Newly Elected Chair & Co-Chair (May 2012 - May 2018) Read More... Michael Schwarzschild, MD, PhD, Chair Hubert Fernandez, MD, Co-Chair |
|
|
| Karen Marder, MD, MPH (Chair); |
| Caroline Tanner, MD, PhD (Co-chair): |
|
Michael McDermott, PhD, Joel Perlmutter, MD, Cathi-Ann Thomas, MS, RN, CNRN, Daniel Weintraub, MD; Ex-officio members: Eric A. Macklin, PhD, Karen Rabinowitz, JD, Associate Counsel, Cindy Casaceli, MBA, Roseanna Battista, BS, Administrative Manager, and Donna Moszkowicz,CMP, Development and Event Manager. Newly Elected: Investigator, Connie Marras, MD, PhD & Coordinator, Deborah Fontaine, RNCS, MS to begin term May 2012. |
| The PSG Executive Committee oversees all the PSG study steering committees, the Scientific Review Committee, the Mentoring Committee, the Nominating Committee, the Credentials Committee, the Publications Committee, the Standards Committee, the Study Budget Committee, and the Symposia Committee (please see the PSG Standing Committee Members list). The Executive Committee is also responsible for overseeing the PSG working groups (Cognitive/Psychiatric (Behavior), Biomarkers, Genetics and Environmental Risk, Other Non-Motor Features of PD, Functional Neurosurgical and Classic Motor) that are responsible for developing new PSG projects. PSG members interested in joining a working group may contact the Chair of that group. |
